Paysign (Nasdaq:PAYS) - Hisse Senedi Fiyatı, Haberler ve Analizler

PAYS Stoklara Genel Bakış

Paysign, Inc. ön ödemeli kart programları, kapsamlı hasta karşılama teklifleri, dijital bankacılık hizmetleri ve işletmeler, tüketiciler ve devlet kurumları için entegre ödeme işleme hizmetleri sunmaktadır. Daha fazla detay

PAYS temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	1/6
Geçmiş Performans	6/6
Finansal Sağlık	6/6
Temettüler	0/6

Ödüller

Gelirin yılda 10.55% oranında artması öngörülüyor

Kazançlar geçen yıl 420.5% oranında arttı

Analistler hisse senedi fiyatının 101% oranında artacağı konusunda hemfikir

Risk Analizi

Önümüzdeki 3 yıl boyunca kazançların yılda ortalama 24.1% oranında düşmesi öngörülüyor

Son 3 ayda önemli miktarda içeriden satış gerçekleşti

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

WarrenAI

Based on Analyst Price Targets

Soaring Patient Affordability Growth Fuels Revenue But Shrinking Margins Loom

Key Takeaways Rapid growth in patient affordability programs and onboarding major pharmaceutical accounts likely to significantly boost revenue. Strategic expansion and investments in plasma centers and IT aim to improve long-term revenue and efficiency.

View narrative

US$6.81

50.2% undervalued

10.80%

Revenue growth p.a.

6 days ago

Paysign, Inc. Rakipler

Cass Information Systems

NasdaqGS:CASS

US$608.2m

International Money Express

NasdaqCM:IMXI

US$662.1m

Cantaloupe

NasdaqGS:CTLP

US$692.6m

Usio

NasdaqGM:USIO

US$42.6m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Paysign
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	US$3.39
52 Haftanın En Yüksek Seviyesi	US$5.59
52 Haftanın En Düşük Seviyesi	US$2.22
Beta	0.96
11 Aylık Değişim	-8.50%
3 Aylık Değişim	-27.72%
1 Yıllık Değişim	43.04%
33 Yıllık Değişim	87.29%
5 Yıllık Değişim	-67.84%
Halka arzdan bu yana değişim	653.33%

Son Haberler & Güncellemeler

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Nov 20

Recent updates

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Nov 20

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

Sep 07

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 02

Paysign: Expect Rapid Growth In Its Pharma Business

Jun 30

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

Apr 26

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Aug 13

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

Jun 14

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?

May 16

PaySign: A 'Backdoor' $2 Stagflation Play

Mar 29

Paysign: My Top Rebound Pick For 2022

Dec 28

Paysign: The Plasma Toll Booth

Sep 23

PaySign's Post-Pandemic Payoff

Sep 07

Why PaySign Is A Very Good Company

Dec 28

PaySign: Long-Term Story Still Intact

Dec 21

Paysign reports Q3 results

Nov 17

Hissedar Getirileri

	PAYS	US Diversified Financial	US Pazar
7D	2.7%	1.6%	2.2%
1Y	43.0%	33.9%	32.6%

Getiri vs. Endüstri: PAYS geçen yıl % 33.9 oranında getiri sağlayan US Diversified Financial sektörünü aştı.

Getiri vs Piyasa: PAYS geçen yıl % 32.6 oranında getiri sağlayan US Piyasasını aştı.

Fiyat Oynaklığı

Is PAYS's price volatile compared to industry and market?
PAYS volatility
PAYS Average Weekly Movement	6.4%
Diversified Financial Industry Average Movement	5.1%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.8%
10% least volatile stocks in US Market	3.1%

İstikrarlı Hisse Senedi Fiyatı: PAYS son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: PAYS 'nin haftalık oynaklığı ( 6% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
1995	123	Mark Newcomer	www.paysign.com

Paysign, Inc. ön ödemeli kart programları, kapsamlı hasta ödeme teklifleri, dijital bankacılık hizmetleri ve işletmeler, tüketiciler ve devlet kurumları için entegre ödeme işleme hizmetleri sunmaktadır. Ürün teklifleri arasında kurumsal ödüller, ön ödemeli hediye kartları, genel amaçlı yeniden yüklenebilir banka kartları, çalışan teşvikleri, tüketici iadeleri, bağışçı tazminatı, klinik deneyler, sağlık hizmeti geri ödeme ödemeleri ve ilaç ödeme yardımı ve banka kartıyla erişilebilen vadesiz mevduat hesapları için çözümler bulunmaktadır. Şirket, ön ödemeli kart çözümlerini Paysign markası altında pazarlamaktadır.

Paysign, Inc. Temel Bilgiler Özeti

Paysign'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
PAYS temel i̇stati̇sti̇kler
Piyasa değeri	US$187.42m
Kazançlar(TTM)	US$8.07m
Gelir(TTM)	US$56.47m

22.5x

F/K Oranı

3.2x

P/S Oranı

PAYS aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
PAYS gelir tablosu (TTM)
Gelir	US$56.47m
Gelir Maliyeti	US$26.33m
Brüt Kâr	US$30.14m
Diğer Giderler	US$22.07m
Kazançlar	US$8.07m

Son Raporlanan Kazançlar

Sep 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	0.15
Brüt Marj	53.37%
Net Kâr Marjı	14.28%
Borç/Özkaynak Oranı	0%

PAYS uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

PAYS Stoklara Genel Bakış

Ödüller

Risk Analizi

Soaring Patient Affordability Growth Fuels Revenue But Shrinking Margins Loom

Paysign, Inc. Rakipler

NasdaqGS:CASS

US$608.2m

NasdaqCM:IMXI

US$662.1m

NasdaqGS:CTLP

US$692.6m

NasdaqGM:USIO

US$42.6m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Investor sentiment deteriorates as stock falls 15%

Chief Payments Officer & Director recently sold US$100k worth of stock

Consensus EPS estimates increase by 26%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Paysign, Inc. Reiterates Earnings Guidance for the Year 2024

Recent updates

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Investor sentiment deteriorates as stock falls 15%

Chief Payments Officer & Director recently sold US$100k worth of stock

Consensus EPS estimates increase by 26%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Paysign, Inc. Reiterates Earnings Guidance for the Year 2024

Do Paysign's (NASDAQ:PAYS) Earnings Warrant Your Attention?

New minor risk - Insider selling

Consensus EPS estimates fall by 22%, revenue upgraded

Price target increased by 7.5% to US$6.58

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Paysign, Inc. (NASDAQ:PAYS) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Paysign, Inc. Revises Earnings Guidance for the Full Year 2024

Second quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment improves as stock rises 34%

Paysign: Expect Rapid Growth In Its Pharma Business

Independent Director exercised options to buy US$85k worth of stock.

Consensus EPS estimates increase by 33%

Price target increased by 8.9% to US$6.13

First quarter 2024 earnings released: EPS: US$0.006 (vs US$0.003 loss in 1Q 2023)

Paysign, Inc. (NASDAQ:PAYS) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 30%, revenue upgraded

PaySign, Inc., Annual General Meeting, May 03, 2024

Here's Why We Think PaySign (NASDAQ:PAYS) Is Well Worth Watching

Price target increased by 14% to US$5.25

Full year 2023 earnings: EPS and revenues exceed analyst expectations

CFO & Treasurer exercised options and sold US$79k worth of stock

PaySign, Inc. Announces Executive Changes

Revenues Tell The Story For PaySign, Inc. (NASDAQ:PAYS)

Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of the Common Stock of Paysign, Inc

Consensus EPS estimates increase by 25%

New major risk - Earnings quality

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Market cap size

Consensus EPS estimates fall by 50%

PaySign, Inc. Reaffirms Earnings Guidance for the Year 2023

Second quarter 2023 earnings released: US$0.002 loss per share (vs US$0.004 loss in 2Q 2022)

Co-Founder exercised options and sold US$71k worth of stock

New minor risk - Market cap size

Consensus EPS estimates fall by 20%

First quarter 2023 earnings released: US$0.003 loss per share (vs US$0.006 loss in 1Q 2022)

Consensus EPS estimates increase by 36%

Price target increased by 13% to US$4.31

CFO & Treasurer recently sold US$101k worth of stock

PaySign, Inc. Elects Jeffrey B. Newman to Its Board of Directors

Consensus EPS estimates have been upgraded.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

PaySign, Inc. Provides Earnings Guidance for the Fiscal Year 2022

General Counsel exercised options to buy US$54k worth of stock.

The Recovery At PaySign Has Legs

Earnings Update: Here's Why Analysts Just Lifted Their PaySign, Inc. (NASDAQ:PAYS) Price Target To US$3.75

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to US$3.75

PaySign, Inc. Provides Revenue Guidance for the Third and Fourth Quarter of 2022

Calculating The Fair Value Of PaySign, Inc. (NASDAQ:PAYS)

At US$1.42, Is PaySign, Inc. (NASDAQ:PAYS) Worth Looking At Closely?